These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8732061)

  • 1. [Effects of vesnarinone on L-type single Ca2+ channel current in cultured ventricular myocytes of embryonic chick].
    Zhang Y; Li H; Lan T; Zeng X
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Dec; 26(4):403-7. PubMed ID: 8732061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of berberine on single Ca2+ channel current in cultured embryonic chick ventricular myocytes].
    Zhou Z; Lan T; Li H; Zhang Y; Wang Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Sep; 26(3):287-90. PubMed ID: 8586394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inotropic effect of novel domestic cardiotonic agent, vesnarinone--test in vitro].
    Han W; Qin Y; Zhang Z; Zhou S; Yang Z
    Hua Xi Yi Ke Da Xue Xue Bao; 1994 Sep; 25(3):316-20. PubMed ID: 7896252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of vesnarinone (OPC-8212) on Ca(2+)-activated K channels and cytosolic Ca2+ in cultured smooth muscle cells from porcine coronary artery.
    Saito K; Nakaya Y; Miyoshi Y; Wakatsuki T; Nomura M; Shono M
    Jpn Heart J; 1994 Jan; 35(1):61-71. PubMed ID: 8201782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of calcium current by low-Km cyclic AMP phosphodiesterases in cardiac cells.
    Fischmeister R; Hartzell HC
    Mol Pharmacol; 1990 Sep; 38(3):426-33. PubMed ID: 1698253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation on SCH00013, a novel cardiotonic agent with Ca++ sensitizing action. 1st communication: phosphodiesterase III inhibitory effect and class III antiarrhythmic effect in guinea-pig heart.
    Hino M; Sugawara H; Yoshimura A; Ogura A; Yoshioka K; Sakato M; Endoh M
    Arzneimittelforschung; 1999 May; 49(5):398-406. PubMed ID: 10367101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium entry via L-type calcium channels acts as a negative regulator of adenylyl cyclase activity and cyclic AMP levels in cardiac myocytes.
    Yu HJ; Ma H; Green RD
    Mol Pharmacol; 1993 Oct; 44(4):689-93. PubMed ID: 7694067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two isoforms of cGMP-inhibited cyclic nucleotide phosphodiesterases in human tissues distinguished by their responses to vesnarinone, a new cardiotonic agent.
    Masuoka H; Ito M; Sugioka M; Kozeki H; Konishi T; Tanaka T; Nakano T
    Biochem Biophys Res Commun; 1993 Jan; 190(2):412-7. PubMed ID: 8381275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine.
    Katano Y; Endoh M
    J Cardiovasc Pharmacol; 1992; 20(5):715-22. PubMed ID: 1280732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide regulates the calcium current in isolated human atrial myocytes.
    Kirstein M; Rivet-Bastide M; Hatem S; Bénardeau A; Mercadier JJ; Fischmeister R
    J Clin Invest; 1995 Feb; 95(2):794-802. PubMed ID: 7860763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of cAMP phosphodiesterase III activity by the cardiotonic agent saterinone in guinea pig myocardium.
    Brunkhorst D; von der Leyen H; Meyer W; Schmidt-Schumacher C; Scholz H
    Arzneimittelforschung; 1988 Sep; 38(9):1293-8. PubMed ID: 2852013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphodiesterase isozyme inhibition, activation of the cAMP system, and positive inotropy mediated by milrinone in isolated guinea pig cardiac muscle.
    Silver PJ; Harris AL; Canniff PC; Lepore RE; Bentley RG; Hamel LT; Evans DB
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):530-40. PubMed ID: 2470989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential modulation of cytokine production by drugs: implications for therapy in heart failure.
    Matsumori A; Ono K; Sato Y; Shioi T; Nose Y; Sasayama S
    J Mol Cell Cardiol; 1996 Dec; 28(12):2491-9. PubMed ID: 9004165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
    Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
    Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive inotropic and chronotropic effects of toborinone and its electrophysiological properties in the isolated hearts of rabbits and guinea-pigs.
    Takase H; Orito K; Mori T; Fujiki H; Sekiguchi K; Tominaga M; Iijima T
    Arzneimittelforschung; 1996 Jun; 46(6):579-86. PubMed ID: 8767347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle.
    Endoh M; Yanagisawa T; Taira N; Blinks JR
    Circulation; 1986 Mar; 73(3 Pt 2):III117-33. PubMed ID: 2417745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic response and effects on myocardial energetics of 3-cyano-2-morpholino-5-(pyrid-4-yl)pyridine (AWD 122-14) in anesthetized minipigs.
    Rohde E; Wiesner B; Muschick P
    Pharmazie; 1993 Sep; 48(9):690-4. PubMed ID: 8234405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carvedilol and vesnarinone: new antiarrhythmic approach in heart failure therapy.
    Cheng JH; Kamiya K; Kodama I
    Acta Pharmacol Sin; 2001 Mar; 22(3):193-200. PubMed ID: 11742564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of amrinone and milrinone on myocardial ischemia extent and infarct size in isolated rabbit hearts.
    Rump AF; Blazincic B; Klaus W
    Arzneimittelforschung; 1993 Dec; 43(12):1262-6. PubMed ID: 8141811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide synthase (NOS3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart. Regulation of NOS3 transcription in vitro and in vivo by cyclic adenosine monophosphate in rat cardiac myocytes.
    Belhassen L; Kelly RA; Smith TW; Balligand JL
    J Clin Invest; 1996 Apr; 97(8):1908-15. PubMed ID: 8621775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.